L520 (Carbidopa and Levodopa Extended-Release 50 mg / 200 mg)
Pill with imprint L520 is Purple, Elliptical/Oval and has been identified as Carbidopa and Levodopa Extended-Release 50 mg / 200 mg. It is supplied by Alembic Pharmaceuticals Inc.
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L520
Carbidopa and Levodopa Extended-Release
- Imprint
- L520
- Strength
- 50 mg / 200 mg
- Color
- Purple
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alembic Pharmaceuticals Inc.
- National Drug Code (NDC)
- 62332-0333
Related images for "L520"
More about carbidopa / levodopa
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (85)
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Carbidopa and levodopa enteral
- Carbidopa and levodopa (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets
Other brands
Sinemet, Rytary, Duopa, Sinemet CR, Parcopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.